BACKGROUND Dyslipidaemia is common in patients with chronic renal failure (CRF), and there is increasing evidence to support the role of dyslipidaemia as a contributing factor in the progression of chronic renal disease. However, few prospective studies have been carried out which address the possible relationship between dyslipidaemia and the rate of progression of renal disease in patients wi...

BACKGROUND Dysglycaemia defined as type 2 diabetes (T2DM) and impaired glucose tolerance (IGT), increases the risk of cardiovascular disease (CVD). The negative impact is more apparent in the presence of hypertension and/or dyslipidaemia. Thus, it seems reasonable to screen for dysglycaemia in patients treated for hypertension and/or dyslipidaemia. A simple screening algorithm would enhance the...

Objective: To identify potential differences between concentrations of thrombogenic markers associated to coronary obstruction in men and women. Patients and Methods: We included 502 consecutive patients (251 men and 251 women), with a mean age of 63.94(11.26) and 66.08(10.58) years respectively. In all patients coronary arteriography was performed, either by presenting an acute coronary episod...